Track the 万泰生物 stock price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 万泰生物 has logged 21 insider filings. Market capitalisation: €37.5bn. The latest transaction was disclosed on 28 May 2025 (Sale). Among the most active insiders: 赵义勇. Every trade is free.
21
Insider Decl.
n/a
Thresholds
€2,491
1 ops.
Buy Volume
€111m
20 ops.
Sell Volume
11Σ signal
Buys €2,491€111m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,859 of 29,063 companies
31.7
score / 100
Value
30
Quality
34
FCF yld-1.9%
Earn yld-1.1%
EV/EBITDA·
ROE-3.3%
Gross mgn49%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
